In May 2013, Mitalipov was the first scientist in the world to demonstrate the successful use of somatic cell nuclear transfer, or SCNT, to
produce human embryonic stem cells from an individual's skin cell.
Not exact matches
Just before Thanksgiving, news broke about a new
stem - cell technique that could
produce the equivalent of
embryonic stem cells (ESCs) but without using or destroying
human embryos.
«We've figured out for the first time how to
produce these cells from
human embryonic stem cells literally by the billions and billions,» Lanza says.
Scientists, with practice, have now been able to make nuclear transfer nearly routine to
produce cattle, cats, mice, sheep, goats, pigs, and — as a Korean team announced in May — even
human embryonic stem (ES) cells.
In May 2005, Hwang and his colleagues reported that it had
produced 11 new
human embryonic stem (ES) cell lines that carried the genetic signature of patients with diabetes, spinal cord injury, or a genetic blood disorder (Science, 20 May, p. 1096).
In the past 3 years, the state has lured two key members of the Victorian team that
produced the world's second
human embryonic stem cell line.
«Giant leap for diabetes: From
human embryonic stem cells to billions of
human insulin
producing cells.»
Many scientists argue that so - called research cloning, in which cloned
human embryos might be used to
produce embryonic stem (ES) cells, could be a boon to medicine.
This year, a team led by the Hebrew University of Jerusalem finally
produced haploid
human embryonic stem cells by forcing unfertilized egg cells to divide.
One team in Japan, and another in the US, have independently shown it is possible to
produce embryonic - like
stem cells directly from a patient's own skin cells without having to create and destroy a cloned
human embryo first.
In 2009, Reijo Pera showed that it is possible to generate functional, sperm -
producing germ cells from
human embryonic stem cells grown under certain conditions in the laboratory.
If I recall correctly, his paper had been published in Science, and it had been fast - tracked in what seemed transparently to be part of a political effort to sell the public on
human cloning to
produce patient - specific
embryonic stem cells.
The state constitutional amendment now protects the right to conduct research to
produce embryonic stem cells, while banning cloning to
produce a
human baby.
Until recently, such cells could be
produced only by destroying
human embryos and harvesting
embryonic stem cells.
A research team said it has
produced stratified retinal tissues from
human embryonic stem cells for the first time in...
Even though different cell types were used as the initial starting materials, and they were made to
produce different sets of proteins, both groups identified and isolated cells nearly identical to
human embryonic stem cells, and did so in the same timeframe.
The guidelines were originally
produced to offer a common set of ethical standards for the responsible conduct of research using
human embryonic stem cells, which have the potential to
produce all the body's cell types.
iPSCs are cells that were originally from adult tissues, but have been forced to
produce proteins that are thought to be essential for the pluripotency of
human embryonic stem cells.
The bill, Senate File 162, carves out an exception to Iowa's 2002 ban on
human cloning allowing researchers to use cloning techniques to
produce embryonic stem cells for medical study.
The discovery, by scientists at Kyoto University and the University of Wisconsin - Madison, seemed to promise a way out of the bitter debates over
embryonic -
stem - cell research: rather than using
human embryos as a source of
stem cells,
produce them from adult cells.
The Society believes that research involving the transfer of a
human nucleus into an animal egg will lead to important new knowledge about cell nuclear replacement (CNR) technology and, if it were to prove possible to
produce embryonic stem cells by this route, would increase understanding of how to programme these cells to develop into different tissue types.
ViaCyte grows replacement insulin -
producing cells from
human embryonic stem cells, which are placed in a semipermeable pouch.
Forbes, Robert Langreth, February 20, 2008: In progress toward a
stem - cell treatment for diabetes, researchers at a small San Diego biotech company have devised a procedure for turning
human embryonic stems cells into insulin -
producing cells inside mice.
Kadimastem's product, AstroRx ® is a
human embryonic stem cell (hESC)- based treatment for amyotrophic lateral sclerosis (ALS), based on astrocytes
produced from
stem cells.